glp-1 and colonoscopy Impact of glucagon-like peptide-1 receptor agonists on outcomes: a systematic review meta-analysis Impact of Glucagon-like Peptide-1 Receptor

Staying informed about official payer announcements is crucial, as enrollment rules and step-therapy requirements often shape what patients actually pay at the pharmacy

Additional studies, including randomised controlled trials, will be needed to corroborate our findings and to explore the full therapeutic potential of the GLP-1 receptor agonist-SGLT-2 inhibitor combination among patients with type 2 diabetes

Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease

1-10 mg/kg in animal studies KPV studies: 100 micromolar oral concentrations in colitis models